Articles

Lilly separating manufacturing of animal health drugs

Eli Lilly and Co. is in the process of separating the manufacturing of its animal health drugs from the facilities used to make its traditional pharmaceuticals, a move that potentially could make it easier to spin off the division one day.

Read More
rop-anthem-120715-2col.jpg

Investors betting no on Anthem mega-deal

Lots of investors are betting health insurance giants Anthem Inc. and Cigna Corp. won’t ever make it to the altar—an outlook driven by concerns antitrust regulators or other obstacles will prevent consummating the $45 billion deal.

Read More

UnitedHealth says it should have waited on Obamacare

UnitedHealth Group Inc. should have stayed out of Obamacare’s new individual markets longer, the CEO of the health insurer said Tuesday. The company expects losses from the plans this year and next to total more than a half-billion dollars.

Read More

Bosma backs proposal to require pseudoephedrine prescription

Bosma’s support could give the proposal its first real life in the General Assembly, which has for years eschewed prescription proposals in favor of laws that require pharmacies to track the people who purchase drugs containing pseudoephedrine, one of the ingredients that can be used to make meth.

Read More